BRICKELL BIOTECH, INC. — Form D
BRICKELL BIOTECH, INC. of MIAMI, FL, a company, filed a Form D exempt-offering notice with the SEC on 2015-02-19. The offering totals $10.0M, of which $7.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-02-19
- Form: D
- Accession: 0001497233-15-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $7.3M
- Remaining: $2.7M
- Investors: 30
- Date of first sale: 2015-02-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-234312
Issuer
- Name: BRICKELL BIOTECH, INC.
- CIK: 0001497233
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 2600 SW 3RD AVENUE, SUITE 350, MIAMI, FL, 33129
- Phone: 786-304-2083
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| George B Abercrombie | Director | Miami, FL |
| Reginald L Hardy | Director | Miami, FL |
| William D Ju | Director | Miami, FL |
| Charles W Stiefel | Director | Miami, FL |
| Dennison T Veru | Director | Fort Lee, NJ |
| David W Angulo | Executive Officer | Miami, FL |
| Charles J Betlach, Ph.D. | Executive Officer | Miami, FL |
| Richard C Bulman, Jr. | Executive Officer | Miami, FL |
| Gerard S Coombs, CPA | Executive Officer | Miami, FL |
| Reginald L Hardy | Executive Officer | Miami, FL |
| Andrew J Sklawer | Executive Officer | Miami, FL |
| Bradley R Goldman | Director | Fort Lee, NJ |
| David E Cohen | Director | Basking Ridge, NJ |
| Glenn E Prestwich | Director | Miami, FL |
| Gerald S Coombs, CPA | Executive Officer | Miami, FL |
| Glenn R Prestwich | Director | Fort Lauderdale, FL |
Other filings by this issuer (3)
More